A Screen for PKN3 Substrates Reveals an Activating Phosphorylation of ARHGAP18

Michal Dibus1,2, Jan Brábek1,2, Daniel Rösel1,2

  • 1Department of Cell Biology, Charles University, Viničná 7, 12800 Prague, Czech Republic.

Insights

Researchers identified new protein kinase N3 (PKN3) substrates, revealing a feedback loop where PKN3 activates ARHGAP18 to regulate RhoA signaling, crucial for understanding cancer progression.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Cancer Research

Background:

  • Protein kinase N3 (PKN3) is a serine/threonine kinase involved in tumor progression.
  • PKN3's substrates and effector proteins are not well understood, limiting therapeutic target identification.

Purpose of the Study:

  • To identify novel substrates of PKN3 using phosphoproteomic screening.
  • To investigate the functional relationship between PKN3 and its newly identified substrate, ARHGAP18.

Main Methods:

  • Utilized analog-sensitive PKN3 for phosphoproteomic screening.
  • Performed in vitro kinase assays to validate PKN3-ARHGAP18 interaction and phosphorylation.
  • Assessed the impact of PKN3-mediated phosphorylation on ARHGAP18's Rho GTPase-activating protein (GAP) activity.

Main Results:

  • Identified ARHGAP18 as a novel substrate of PKN3.
  • Confirmed direct phosphorylation of ARHGAP18 by PKN3 in vitro, with interaction mediated by ARHGAP18's N-terminal region.
  • Demonstrated that PKN3 phosphorylation enhances ARHGAP18's GAP activity, leading to negative regulation of active RhoA.

Conclusions:

  • Discovered a new set of potential PKN3 substrates.
  • Elucidated a novel negative feedback mechanism in Rho signaling involving PKN3-induced activation of ARHGAP18.
  • This finding offers insights into cancer progression pathways regulated by PKN3 and RhoA.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.9K
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
9.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.5K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.8K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.8K